Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The postmenopausal hormone replacement therapy-related breast cancer risk is decreased in women carrying the CYP2C19*17 variant.
Justenhoven C, Obazee O, Winter S, Couch FJ, Olson JE, Hall P, Hannelius U, Li J, Humphreys K, Severi G, Giles G, Southey M, Baglietto L, Fasching PA, Beckmann MW, Ekici AB, Hamann U, Baisch C, Harth V, Rabstein S, Lotz A, Pesch B, Brüning T, Ko YD, Brauch H. Justenhoven C, et al. Among authors: rabstein s. Breast Cancer Res Treat. 2012 Jan;131(1):347-50. doi: 10.1007/s10549-011-1827-1. Epub 2011 Oct 26. Breast Cancer Res Treat. 2012. PMID: 22037784 No abstract available.
Investigation of genetic variants of genes of the hemochromatosis pathway and their role in breast cancer.
Abraham BK, Justenhoven C, Pesch B, Harth V, Weirich G, Baisch C, Rabstein S, Ko YD, Brüning T, Fischer HP, Haas S, Brod S, Oberkanins C, Hamann U, Brauch H; GENICA Network. Abraham BK, et al. Among authors: rabstein s. Cancer Epidemiol Biomarkers Prev. 2005 May;14(5):1102-7. doi: 10.1158/1055-9965.EPI-05-0013. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 15894659
One-carbon metabolism and breast cancer risk: no association of MTHFR, MTR, and TYMS polymorphisms in the GENICA study from Germany.
Justenhoven C, Hamann U, Pierl CB, Rabstein S, Pesch B, Harth V, Baisch C, Vollmert C, Illig T, Brüning T, Ko Y, Brauch H. Justenhoven C, et al. Among authors: rabstein s. Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):3015-8. doi: 10.1158/1055-9965.EPI-05-0592. Cancer Epidemiol Biomarkers Prev. 2005. PMID: 16365030 No abstract available.
Breast cancer: a candidate gene approach across the estrogen metabolic pathway.
Justenhoven C, Hamann U, Schubert F, Zapatka M, Pierl CB, Rabstein S, Selinski S, Mueller T, Ickstadt K, Gilbert M, Ko YD, Baisch C, Pesch B, Harth V, Bolt HM, Vollmert C, Illig T, Eils R, Dippon J, Brauch H. Justenhoven C, et al. Among authors: rabstein s. Breast Cancer Res Treat. 2008 Mar;108(1):137-49. doi: 10.1007/s10549-007-9586-8. Epub 2007 Jun 23. Breast Cancer Res Treat. 2008. PMID: 17588204
CYP2C19*17 is associated with decreased breast cancer risk.
Justenhoven C, Hamann U, Pierl CB, Baisch C, Harth V, Rabstein S, Spickenheuer A, Pesch B, Brüning T, Winter S, Ko YD, Brauch H. Justenhoven C, et al. Among authors: rabstein s. Breast Cancer Res Treat. 2009 May;115(2):391-6. doi: 10.1007/s10549-008-0076-4. Epub 2008 Jun 3. Breast Cancer Res Treat. 2009. PMID: 18521743
Polymorphic loci of E2F2, CCND1 and CCND3 are associated with HER2 status of breast tumors.
Justenhoven C, Pierl CB, Haas S, Fischer HP, Hamann U, Baisch C, Harth V, Spickenheuer A, Rabstein S, Vollmert C, Illig T, Pesch B, Brüning T, Dippon J, Ko YD, Brauch H. Justenhoven C, et al. Among authors: rabstein s. Int J Cancer. 2009 May 1;124(9):2077-81. doi: 10.1002/ijc.24198. Int J Cancer. 2009. PMID: 19142864 Free article.
77 results